(ZIQ) BMO MSCI EAFE High Quality - Ratings and Ratios
International Stocks, Developed Markets, High Quality Equities
Description: ZIQ BMO MSCI EAFE High Quality
The BMO MSCI EAFE High Quality Index ETF (TO:ZIQ) is a Global Equity ETF listed in Canada, providing investors with exposure to high-quality international equities. As a passively managed fund, it tracks the Morningstar Global Markets GR CAD Index, aiming to replicate its performance.
With an Assets Under Management (AUM) of $227.95M CAD, ZIQ has established a stable presence in the market. To evaluate its performance, key metrics such as tracking error, expense ratio, and dividend yield should be considered. A low tracking error would indicate that the ETF is effectively replicating the index, while a competitive expense ratio would help minimize costs for investors. Additionally, a stable dividend yield could provide a regular income stream.
From a technical analysis perspective, ZIQs price action suggests a stable trend, with the short-term and long-term moving averages (SMA20 and SMA50) indicating a relatively flat profile. The SMA200, however, shows a positive slope, suggesting a longer-term uptrend. To further assess the ETFs potential, investors should examine its relative strength index (RSI), Bollinger Bands, and other technical indicators to gauge its momentum and potential for future growth.
To make an informed investment decision, its essential to evaluate ZIQs underlying holdings, sector allocation, and geographic distribution. A diversified portfolio with a mix of developed market equities, a balanced sector allocation, and minimal overlap with other holdings in an investors portfolio could make ZIQ an attractive addition. Key performance indicators (KPIs) such as return on equity (ROE), price-to-earnings (P/E) ratio, and the ETFs Sharpe ratio should also be analyzed to assess its risk-adjusted returns and overall investment quality.
Additional Sources for ZIQ ETF
ZIQ ETF Overview
Market Cap in USD | 159m |
Category | Global Equity |
IPO / Inception | 2024-10-24 |
ZIQ ETF Ratings
Growth Rating | 9.76 |
Fundamental | - |
Dividend Rating | 48.5 |
Rel. Strength | -9.05 |
Analysts | - |
Fair Price Momentum | 27.27 CAD |
Fair Price DCF | - |
ZIQ Dividends
Dividend Yield 12m | 0.84% |
Yield on Cost 5y | 0.84% |
Annual Growth 5y | 223.33% |
Payout Consistency | 100.0% |
Payout Ratio | % |
ZIQ Growth Ratios
Growth Correlation 3m | 20.2% |
Growth Correlation 12m | 66.8% |
Growth Correlation 5y | 66.8% |
CAGR 5y | -0.62% |
CAGR/Max DD 5y | -0.04 |
Sharpe Ratio 12m | -0.28 |
Alpha | -9.68 |
Beta | 0.415 |
Volatility | 16.27% |
Current Volume | 1.1k |
Average Volume 20d | 1k |
Stop Loss | 28.8 (-3.1%) |
As of August 03, 2025, the stock is trading at CAD 29.73 with a total of 1,098 shares traded.
Over the past week, the price has changed by -4.92%, over one month by -3.97%, over three months by -1.04% and over the past year by -0.62%.
Neither. Based on ValueRay´s Analyses, BMO MSCI EAFE High Quality is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 9.76 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ZIQ is around 27.27 CAD . This means that ZIQ is currently overvalued and has a potential downside of -8.27%.
BMO MSCI EAFE High Quality has no consensus analysts rating.
According to our own proprietary Forecast Model, ZIQ BMO MSCI EAFE High Quality will be worth about 30.5 in August 2026. The stock is currently trading at 29.73. This means that the stock has a potential upside of +2.62%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 30.5 | 2.6% |